Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05141890 · ClinicalTrials.gov registry record · NA

Probiotics for Inflammation in Pediatric Chronic Pain

A NA study of Chronic Pain and Body Mass Index >=85th Percentile, sponsored by Medical College of Wisconsin.

Active
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT05141890 is a NA study of Chronic Pain and Body Mass Index >=85th Percentile that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 39 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05141890, a NA study of Chronic Pain and Body Mass Index >=85th Percentile, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

To examine benefits of a probiotic for youth with chronic pain and a Body Mass Index \>=85th percentile.

Interventions

  • DIETARY_SUPPLEMENT Lactobacillus Plantarum

Study Locations (1)

Wisconsin

  • Children's Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2022-04-25
Est. Completion 2026-06-01
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT05141890

The ClinicalTrials.gov registry entry for NCT05141890 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Lactobacillus Plantarum is the first listed.

NCT05141890 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05141890 about?

NCT05141890 is a clinical study titled "Probiotics for Inflammation in Pediatric Chronic Pain". To examine benefits of a probiotic for youth with chronic pain and a Body Mass Index \>=85th percentile.

What is the current status of trial NCT05141890?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2022-04-25. Estimated completion is 2026-06-01.

What conditions does trial NCT05141890 study?

This clinical trial studies the following conditions: Chronic Pain, Body Mass Index >=85th Percentile.

What interventions are being tested in trial NCT05141890?

The interventions under investigation include: Lactobacillus Plantarum (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05141890?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05141890 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.